Pyoderma gangrenosum as a rare manifestation of myelodysplastic syndrome in a pediatric patient: A case report Authors: Adam C. Yu, Airiss R. Chan, Loretta Fiorillo Published: 2026 ABSTRACT Pyoderma gangrenosum is a rare neutrophilic dermatosis that presents as rapidly progressive ulcerative lesions, often associated with systemic diseases. Pyoderma gangrenosum remains an uncommon and challenging diagnosis particularly in a pediatric population. We report a 3-year-old male with myelodysplastic syndrome who developed a nonhealing ulcer of the right forearm following minor trauma. The lesion was misdiagnosed as an infection, leading to prolonged antibiotic therapy. The patient underwent surgical debridement and closure of the ulcer with bilateral advancement flaps with biopsies taken. However, the wound dehisced and ulcerated. Due to the progressive nature and lack of response to antimicrobials, pyoderma gangrenosum was suspected and later confirmed through clinical and histopathologic findings. The patient demonstrated significant clinical improvement with 2 months of topical and systemic corticosteroid therapy. This case highlights the challenges of diagnosing pyoderma gangrenosum in pediatric populations, and the utility of histology in management, given the low index of suspicion in children. Introduction Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis characterized by rapidly progressive, painful ulcerative skin lesions. 1 It is often associated with systemic conditions such as inflammatory bowel disease (IBD), autoimmune disorders, and hematologic malignancies, including myelodysplastic syndrome (MDS), acute myeloid leukemia, and lymphoproliferative disorders.1,2 While PG can occur at any age, it is most commonly seen in adults between 20 and 50 years of age, with pediatric cases accounting for only 4% of reported cases. 3 In children, PG frequently presents with a more disseminated pattern, often affecting the head and neck, and lacks the characteristic distribution seen in adults. 3 Approximately 50% of pediatric cases have no identifiable underlying cause. 1 When an associated condition is present, IBD is the most common comorbidity, similar to adult cases, while hematologic disorders are rarely observed in pediatric PG. 1 Pathergy, a phenomenon where minor trauma triggers exaggerated skin reactions, occurs in 62% of cases of pediatric PG. 3 The diagnosis of PG is based on clinical and histopathologic criteria. There are several criteria including the Su criteria, PARACELSUS score, and Delphi consensus. For the Delphi consensus only, the major criteria include a biopsy showing neutrophilic infiltrates at the ulcer edge, while minor criteria consists of the exclusion of infection via histologic stains and tissue cultures, a history of pathergy, a personal history of IBD or inflammatory arthritis, and the presence of rapidly ulcerating papules, vesicles, or pustules. 4 Additional minor features include peripheral erythema, undermined ulcer borders with local tenderness, multiple ulcerations (with at least one on the anterior lower leg), cribriform scarring, and improvement within 1 month of immunosuppressive therapy. 4 This case report highlights the clinical presentation, disease course, and management of a pediatric patient with PG in the context of MDS—a rare but significant association. Case report A 3-year-old male with a history of MDS with suspected progression to acute myeloid leukemia secondary to mosaic trisomy 8 and 19, presented with a nonhealing wound on his right arm after sustaining a minor scrape while playing. Two days later, he developed a fever and received a single dose of cefazolin at a local hospital. Despite this, the wound worsened, leading to his transfer to our tertiary care center, where he was admitted and treated with intravenous ceftriaxone and metronidazole for suspected cellulitis. Initially, the wound showed signs of improvement, but it deteriorated following the accidental removal of a scab during blood work. Initial wound cultures grew methicillin-sensitive Staphylococcus aureus. Nine days later, due to lack of ongoing improvement with antibiotics, he was brought to the operating room for closure with plastic surgery. The patient underwent extensive surgical debridement of the ulcer on his right forearm, roughly 36 cm2 in size with skin biopsies being taken. Despite wound closure with bilateral advancement flap and ongoing antibiotics, he continued to have recurrent fevers, and the wound dehisced and continued to ulcerate, suggestive of pathergy. Given the atypical wound progression and persistent fever, dermatology was consulted. Initial physical examination revealed a 2–3 cm ulcerative lesion with violaceous, undermined borders, and significant surrounding erythema and edema on the right forearm (Figure 1). This progressed quickly into an 8 cm ulcer with violaceous undermined borders. No additional cutaneous lesions were noted, and the patient exhibited no additional symptoms such as arthralgia, chest pain, or gastrointestinal involvement. There was no evidence of lymphangitic spread or purulent drainage. Laboratory investigations showed normal white blood cell and neutrophil counts. Blood cultures remained negative, and no other infectious organisms were identified. (a) Initial presentation of a superficial ulcer on the right arm. (b) Progression of ulceration with peripheral expansion, violaceous erythema, and undermined borders. (c) Lesion postsurgical debridement. (d) Complete resolution with residual scarring following 2 months of systemic and topical corticosteroid therapy. The skin biopsy performed at the time of surgical closure revealed ulcerated epidermis with marked hyperplasia and diffuse neutrophilic infiltrates forming abscesses, accompanied by clusters of foamy macrophages. Stains for bacterial and fungal organisms were negative, ruling out an infectious etiology. Given the absence of microbial organisms on biopsy and the clinical presentation, the dermatopathologist strongly favored a diagnosis of PG. Further supporting this diagnosis were the patient’s history of MDS, pathergy following minor trauma and worsened after surgical intervention, and the presence of a characteristic undermined violaceous ulcer border, along with the lesion’s lack of response to antibiotics. After the diagnosis of PG, the patient was started on systemic immunosuppressive therapy with intravenous methylprednisolone (up to 1 mg/kg/day) along with topical clobetasol (0.05%) and fluticasone (125 µg) applied to dressing changes to control inflammation. Following corticosteroid initiation, the patient showed significant improvement, with resolution of recurrent fevers and development of granulation tissue. However, a relapse occurred when methylprednisolone was tapered below 1 mg/kg/day so he was switched to oral prednisone 1 mg/kg/day to facilitate discharge, resulting in further clinical improvement. No steroid-sparing immunosuppressive agents were initiated during the course of treatment. Diligent wound care with Aquacel was provided throughout his course. After 20 days of further treatment, his corticosteroid dose was gradually tapered again, with the treatment completed after 2 months. At the end of this period, the patient achieved complete, permanent wound healing. Discussion This case highlights the diagnostic challenges of PG in children due to its rarity. This patient’s ulcerating lesion was initially misattributed to infection, leading to prolonged antibiotic use and surgical intervention. The lesion developed after minor trauma, suggesting pathergy, a hallmark of PG. Despite antibiotic therapy, the wound worsened following accidental scab removal, further supporting pathergy as a contributing factor. The persistence of methicillin-sensitive Staphylococcus aureus (MSSA) in wound cultures, likely secondary to the development of the ulcer, complicated the diagnosis, delaying immunosuppressive therapy. PG is an uncommon diagnosis in pediatric populations. Awareness of the difference in pediatric versus adult PG may help facilitate a more timely diagnosis and exclusion of associations and syndromes. A French cohort of 27 pediatric patients with neutrophilic dermatoses, including Sweet syndrome and PG found that atypical forms of neutrophilic dermatoses may be more frequently observed in infants (90%), compared to young children (60%) and adolescents (33%). 5 A large 2016 cohort study of 204 children and 10154 adults with PG found that both adult and pediatric PG patients were more likely to be female, and to have associated arteritis, arthropathy, and colitis, with variable degrees of correlation. Specifically, pediatric PG was more likely to present with gastroenterologic, rheumatologic, and vascular issues and less likely to be associated with malignancy when compared to adult PG. 6 Association of PG with monogenic autoinflammatory conditions should also be considered in early presenting cases in pediatrics, for example, PAPA (Pyogenic Arthritis, Pyoderma gangrenosum, and Acne), PASH (Pyoderma gangrenosum, Acne, and Suppurative Hidradenitis), and PAPASH (Pyogenic Arthritis, Pyoderma gangrenosum, Acne, Suppurative Hidradenitis) PASH syndromes. The pathophysiologic mechanisms underlying PG remain incompletely understood. PG is recognized as an autoinflammatory disorder characterized by abnormal neutrophil activity. Its pathogenesis is multifactorial, involving neutrophil dysfunction, aberrant inflammatory signaling, and genetic susceptibility. 7 Similarly, in MDS, hematopoietic stem cell abnormalities can lead to significant defects in neutrophil activity, including impaired chemotaxis, defective phagocytosis, and dysregulated apoptosis. 8 These impairments contribute to an ineffective immune response, resulting in persistent inflammation and delayed tissue repair, which may contribute to the pathology seen in MDS-associated PG. Additionally, the immune dysregulation of MDS results in a sustained proinflammatory state, 9 which may further exacerbate tissue damage in PG. One cytokine that contributes to this proinflammatory state includes interleukin-8 (IL-8). A primary role of IL-8 is to activate and recruit neutrophils and has been shown to be overexpressed in both MDS and PG.10 –12 The combination of IL-8 overexpression and observed neutrophilic dysfunction suggests a potential pathophysiological mechanism where IL-8-driven immune dysregulation contributes to the comorbid development of PG and MDS. This association also highlights the potential therapeutic role of IL-8 inhibitors in managing PG, particularly in refractory cases that do not respond to corticosteroids. In conclusion, PG is a rare but important consideration in pediatric patients with hematologic disorders, particularly in cases of progressive ulcers unresponsive to antibiotics. This case highlights the diagnostic challenges of PG in the setting of hematologic disease and the importance of recognizing pathergy as a distinguishing feature. Given the potential for delayed diagnosis and inappropriate treatment, clinicians should maintain a high index of suspicion for PG in similar presentations. Early initiation of immunosuppressive therapy is essential for disease control, and a multidisciplinary approach—including dermatology, hematology, infectious disease, and wound care specialists—is critical for optimizing patient outcomes and preventing disease recurrence.